Compare NOV Inc. Common Stock (NOV) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? NOV Inc. Common Stock trades at $18.97 (market cap $6.77B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 3.7× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| NOV | RPRX | |
|---|---|---|
Market Cap | $6.77B | $25.27B |
Volume | 3,592,724 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $21.71 | $63.96 |
52-Week Low | $12.31 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $7.93B | $32.50B |
Dividend Yield | 1.9% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
